BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Houssami N, Costelloe CM. Imaging bone metastases in breast cancer: evidence on comparative test accuracy. Ann Oncol. 2012;23:834-843. [PMID: 21896542 DOI: 10.1093/annonc/mdr397] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Simanek M, Koranda P. SPECT/CT imaging in breast cancer - current status and challenges. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016;160:474-83. [DOI: 10.5507/bp.2016.036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
2 Pires AO, Borges US, Lopes-Costa PV, Gebrim LH, da Silva BB. Evaluation of bone metastases from breast cancer by bone scintigraphy and positron emission tomography/computed tomography imaging. Eur J Obstet Gynecol Reprod Biol 2014;180:138-41. [PMID: 25037283 DOI: 10.1016/j.ejogrb.2014.06.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
3 Xu B, Hu X, Jiang Z, Li H, Chen J, Cui S, Li Q, Liao N, Liu D, Liu J, Lu J, Shen K, Sun T, Teng Y, Tong Z, Wang S, Wang X, Wang X, Wang Y, Wu J, Yuan P, Zhang P, Zhang Q, Zheng H, Pang D, Ren G, Shao Z, Shen Z, Song E, Song S. National consensus in China on diagnosis and treatment of patients with advanced breast cancer. Ann Transl Med 2015;3:242. [PMID: 26605288 DOI: 10.3978/j.issn.2305-5839.2015.09.47] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
4 Oprea-Lager DE, Cysouw MCF, Boellaard R, Deroose CM, de Geus-Oei LF, Lopci E, Bidaut L, Herrmann K, Fournier LS, Bäuerle T, deSouza NM, Lecouvet FE. Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography. Front Oncol 2021;11:772530. [PMID: 34869009 DOI: 10.3389/fonc.2021.772530] [Reference Citation Analysis]
5 Xu B, Hu X, Feng J, Geng C, Jin F, Li H, Li M, Li Q, Liao N, Liu D, Liu J, Liu Q, Lu J, Liu Z, Ma F, Ouyang Q, Pan Y, Shen K, Sun T, Teng Y, Tong Z, Wang B, Wang H, Wang S, Wang S, Wang T, Wang X, Wang X, Wang Y, Wang Z, Wu J, Yan M, Yang J, Yin Y, Yuan P, Zhang J, Zhang P, Zhang Q, Zheng H. Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018). Cancer 2020;126:3867-82. [DOI: 10.1002/cncr.32832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Badraoui R, Boubakri M, Bedbabiss M, Ben-Nasr H, Rebai T. Walker 256/B malignant breast cancer cells improve femur angioarchitecture and disrupt hematological parameters in a rat model of tumor osteolysis. Tumour Biol 2014;35:3663-70. [PMID: 24318993 DOI: 10.1007/s13277-013-1485-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Doré-Savard L, Barrière DA, Midavaine É, Bélanger D, Beaudet N, Tremblay L, Beaudoin JF, Turcotte EE, Lecomte R, Lepage M, Sarret P. Mammary cancer bone metastasis follow-up using multimodal small-animal MR and PET imaging. J Nucl Med 2013;54:944-52. [PMID: 23596003 DOI: 10.2967/jnumed.112.114215] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
8 Zheng H, Yuan C, Cai J, Pu W, Wu P, Li C, Li G, Zhang Y, Zhang J, Guo J, Huang D. Early diagnosis of breast cancer lung metastasis by nanoprobe-based luminescence imaging of the pre-metastatic niche. J Nanobiotechnology 2022;20:134. [PMID: 35292019 DOI: 10.1186/s12951-022-01346-4] [Reference Citation Analysis]
9 Oka S, Kanagawa M, Doi Y, Schuster DM, Goodman MM, Yoshimura H. PET Tracer 18F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models. Theranostics 2017;7:2048-64. [PMID: 28656060 DOI: 10.7150/thno.19883] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
10 Iagaru A, Minamimoto R. Nuclear Medicine Imaging Techniques for Detection of Skeletal Metastases in Breast Cancer. PET Clin 2018;13:383-93. [PMID: 30100077 DOI: 10.1016/j.cpet.2018.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
11 Bansal GJ, Vinayan Changaradil D. Planar Bone Scan Versus Computerized Tomography in Staging Locally Advanced Breast Cancer in Asymptomatic Patients: Does Bone Scan Change Patient Management Over Computerized Tomography? J Comput Assist Tomogr 2018;42:19-24. [PMID: 28786907 DOI: 10.1097/RCT.0000000000000654] [Reference Citation Analysis]
12 Greene LR, Wilkinson D. The role of general nuclear medicine in breast cancer. J Med Radiat Sci 2015;62:54-65. [PMID: 26229668 DOI: 10.1002/jmrs.97] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
13 Bezerra ROF, Recchimuzzi DZ, Dos Santos Mota MM, Garcia MRT, de Menezes MR, Mazo PE, Cerri GG. Whole-Body Magnetic Resonance Imaging in the Oncology Setting: An Overview and Update on Recent Advances. J Comput Assist Tomogr 2019;43:66-75. [PMID: 30015799 DOI: 10.1097/RCT.0000000000000772] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zhang H, Zhu W, Biskup E, Yang W, Yang Z, Wang H, Qiu X, Zhang C, Hu G, Hu G. Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data. J Bone Oncol 2018;11:38-50. [PMID: 29511626 DOI: 10.1016/j.jbo.2018.01.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
15 Koleva-Kolarova RG, Greuter MJ, van Kruchten M, Vermeulen KM, Feenstra T, Buskens E, Glaudemans AW, de Vries EF, de Vries EG, Hospers GA, de Bock GH. The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients. Br J Cancer 2015;112:1617-25. [PMID: 25880006 DOI: 10.1038/bjc.2015.138] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
16 Pasoglou V, Michoux N, Tombal B, Jamar F, Lecouvet FE. wbMRI to detect bone metastases: critical review on diagnostic accuracy and comparison to other imaging modalities. Clin Transl Imaging 2015;3:141-57. [DOI: 10.1007/s40336-015-0120-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
17 Hogan MP, Goldman DA, Dashevsky B, Riedl CC, Gönen M, Osborne JR, Jochelson M, Hudis C, Morrow M, Ulaner GA. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma. J Nucl Med 2015;56:1674-80. [PMID: 26294295 DOI: 10.2967/jnumed.115.161455] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.9] [Reference Citation Analysis]
18 Doré-Savard L, Beaudet N, Tremblay L, Xiao Y, Lepage M, Sarret P. A micro-imaging study linking bone cancer pain with tumor growth and bone resorption in a rat model. Clin Exp Metastasis 2013;30:225-36. [PMID: 22956259 DOI: 10.1007/s10585-012-9530-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
19 Pesapane F, Downey K, Rotili A, Cassano E, Koh DM. Imaging diagnosis of metastatic breast cancer. Insights Imaging 2020;11:79. [PMID: 32548731 DOI: 10.1186/s13244-020-00885-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
20 Wedam SB, Beaver JA, Amiri-Kordestani L, Bloomquist E, Tang S, Goldberg KB, Sridhara R, Ibrahim A, Kim G, Kluetz P, McKee A, Pazdur R. US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic Assessments. J Clin Oncol 2018;36:1225-31. [PMID: 29522361 DOI: 10.1200/JCO.2017.74.6917] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 Niikura N, Hashimoto J, Kazama T, Koizumi J, Ogiya R, Terao M, Oshitanai R, Morioka T, Tsuda B, Okamura T, Saito Y, Iwaisako K, Iwamoto T, Hayashi N, Imai Y, Tokuda Y. Diagnostic performance of 18F-fluorodeoxyglucose PET/CT and bone scintigraphy in breast cancer patients with suspected bone metastasis. Breast Cancer 2016;23:662-7. [DOI: 10.1007/s12282-015-0621-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Puglisi F, Fontanella C, Numico G, Sini V, Evangelista L, Monetti F, Gori S, Del Mastro L. Follow-up of patients with early breast cancer: Is it time to rewrite the story? Critical Reviews in Oncology/Hematology 2014;91:130-41. [DOI: 10.1016/j.critrevonc.2014.03.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
23 Catalano OA, Nicolai E, Rosen BR, Luongo A, Catalano M, Iannace C, Guimaraes A, Vangel MG, Mahmood U, Soricelli A. Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients. Br J Cancer. 2015;112:1452-1460. [PMID: 25871331 DOI: 10.1038/bjc.2015.112] [Cited by in Crossref: 67] [Cited by in F6Publishing: 46] [Article Influence: 9.6] [Reference Citation Analysis]
24 Kong Y, Ma XW, Zhang QQ, Zhao Y, Feng HL. Gastrointestinal stromal tumor with multisegmental spinal metastases as first presentation: A case report and review of the literature. World J Clin Cases 2021; 9(6): 1490-1498 [PMID: 33644220 DOI: 10.12998/wjcc.v9.i6.1490] [Reference Citation Analysis]
25 Cvitkovic F, Mouret-Fourme E. [Epidemiology and clinical features of bone metastases]. Bull Cancer 2013;100:1073-81. [PMID: 24169223 DOI: 10.1684/bdc.2013.1837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Palmedo H, Marx C, Ebert A, Kreft B, Ko Y, Türler A, Vorreuther R, Göhring U, Schild HH, Gerhardt T, Pöge U, Ezziddin S, Biersack H, Ahmadzadehfar H. Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients. Eur J Nucl Med Mol Imaging 2014;41:59-67. [DOI: 10.1007/s00259-013-2532-6] [Cited by in Crossref: 99] [Cited by in F6Publishing: 75] [Article Influence: 11.0] [Reference Citation Analysis]
27 Schaefer AR, Yang L, Park JM, Xiong J, Fajardo LL. Detection and Clinical Significance of Sternal Lesions on Breast MRI. Breast J 2015;21:395-402. [PMID: 25864435 DOI: 10.1111/tbj.12416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]